Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Anthropic recursive self improvement, Brian Patrick Green tech ethics, AI regulation slowdown, Pope Leo XIV AI encyclical, ...

Spread the love“`html The landscape of artificial intelligence is constantly evolving, and the idea of Recursive Self-Improvement (RSI) is gaining traction as a potential game-changer. With ...

As AI moves from experimentation to business-critical operations, leadership teams will need to look beyond pilot outcomes ...

Detailed price information for Roche Holding Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he insists it will actually ship products.